Efficacy of Pemigatinib in Patients With Solid Tumors Characterized by an Alteration of the Gene FGFR in Tumor Cells
Efficacy of Pemigatinib in Patients With Solid Tumors Characterized by an Alteration of the Gene FGFR in Tumor Cells
Recruiting · NCT06653777 · Registry updated 2025-06-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy of Pemigatinib in Patients With Solid Tumors Characterized by an Alteration of the Gene FGFR in Tumor Cells | Solid Tumor, Miscellaneous | Recruiting | Phase 2 | 2025-06-05 | NCT06653777 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Incyte BioSciences France | 1 |
| National Cancer Institute, France | 61 |
| UNICANCER | 111 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre Antoine Lacassagne | Nice | France | 60 |
| CHU de Brest | Brest | France | 18 |
| CHU Poitiers | Poitiers | France | 70 |
| CHU Saint Etienne | Saint-Priest-en-Jarez | France | 6 |
| Institut Curie | Paris | France | 44 |
| Institut de Cancerologie de Lorraine | Vandœuvre-lès-Nancy | France | 5 |